EssilorLuxottica - ADR
ESLOY - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$92.52B
Close$
Earnings Call Q2 2025
July 28, 2025 - AI Summary
Strong Revenue Growth: EssilorLuxottica reported a 7.3% revenue growth at constant currency for H1 2025, with significant momentum across all regions. North America grew by 5.5%, Europe by 9.1%, and Asia-Pacific by 8%, indicating a balanced performance across markets. This consistent growth reflects the success of new product introductions and retail strategies.
Expansion in Wearables and MedTech: The company is investing heavily in MedTech and smart eyewear. The recent acquisition of Optegra Eye Clinics and the launch of Oakley Meta and Ray-Ban Meta smart glasses position EssilorLuxottica for long-term growth in innovative healthcare solutions. This focuses on leveraging AI and data collection for enhancing eye health and overall wellness.
Positive Operational Margins: Despite inflationary pressures and tariffs, EssilorLuxottica maintained a stable adjusted operating margin year-over-year, with effective cost management contributing to the resilience. Operating expenditures (OpEx) decreased by 70 basis points, demonstrating the company's efficiency in controlling costs while continuing to invest in innovation.
Exclusive for Stockcircle Pro members
Sign up
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $92.52 Billion |
|---|---|
| Enterprise Value | $105.90 Billion |
| Annual dividend | $2.32 |
| Dividend yield | 2.21% |
| Earnings per Share | $2.42 |
| Beta | 0.55 |
| Outstanding Shares | 922,398,762 |
Return
| Return on Equity | 12.50% |
|---|---|
| Return on Assets | 7.53% |
| Return on Invested Capital | 13.63% |
Valuation & Multiples
| P/E Ratio | 33.56 |
|---|---|
| PEG | 221.51 |
| Price to Sales | 1.6 |
| Price to Book Ratio | 2.27 |
| Enterprise Value to Revenue | 1.87 |
| Enterprise Value to EBIT | 14.83 |
| Enterprise Value to Net Income | 21 |
| Total Debt to Enterprise | 0.14 |
| Debt to Equity | 0.39 |
Revenue Sources
No data
Last Earnings Call
Report Date
July 28, 2026
EPS Estimate
$2.22
Consensus analyst estimateRevenue Estimate
$17.05 B
Consensus analyst estimateNext Earnings Call
Expected Date
February 17, 2027
EPS Estimate
$1.91
Consensus analyst estimateRevenue Estimate
$17.25 B
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.00%▼ 0.00% |
|---|---|
| Total Invested | $2.16M▼ 59.42% |
| Investors Holding | 12▲ 2.00% |
About EssilorLuxottica
213,909 employees
CEO: Francesco Milleri
EssilorLuxottica S.A., established in Paris, France, in 1849, is a global enterprise dedicated to the design, production, and distribution of a wide range of ophthalmic products, including corrective lenses, eyewear frames, and sunglasse...